Colagrossi, L. Et Al. 2018. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC INFECTIOUS DISEASES , vol.18 .

Colagrossi, L., Hermans, L. E., Salpini, R., Di Carlo, D., Pas, S. D., Alvarez, M., ... Ben-Ari, Z.(2018). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC INFECTIOUS DISEASES , vol.18.

Colagrossi, Luna Et Al. "Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe," BMC INFECTIOUS DISEASES , vol.18, 2018

Colagrossi, Luna Et Al. "Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe." BMC INFECTIOUS DISEASES , vol.18, 2018

Colagrossi, L. Et Al. (2018) . "Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe." BMC INFECTIOUS DISEASES , vol.18.

@article{article, author={Luna Colagrossi Et Al. }, title={Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe}, journal={BMC INFECTIOUS DISEASES}, year=2018}